Zobrazeno 1 - 10
of 39
pro vyhledávání: '"RI Freudenthal"'
Publikováno v:
Pharmacological Research Communications. 6:457-468
The effects of ethynodiol diacetate norethindtone and norethynodrel on the hepatic microsomal drug metabolizing enzyme system of rat were studied. 10 or 50 mg norethynodren/kg or 50 mg norethindrone/kg markedly increased the duration of pentobarital-
Publikováno v:
Analytical Biochemistry. 51:632-636
A method has been developed for the preparation of a high specific activity stereospecifically labeled tritiated NADPH. In this procedure, tritium is enzymatically transferred from d-isocitric acid-2-3H (8 Ci/mmole) to the A face of a pyridine nucleo
Publikováno v:
Toxicology and Applied Pharmacology. 24:125-132
In vitro norethynodrel was found to rapidly metabolize to norethindrone the 3-alpha- and 3 beta-hydroxy metabolites and an unknown complex. From these intermediaries biosynthesis continues to more polar polyhydroxylated products whose hydroxyl positi
Publikováno v:
British Journal of Pharmacology. 44:244-249
1. The distribution of Delta(9)-tetrahydrocannabinol-(14)C in the pregnant and nonpregnant mouse is very similar. High concentrations of radiolabel can be seen in the maternal liver, spleen, lungs, brown fat, adrenal glands, mammary glands, yolk sac
Publikováno v:
Biochemical Pharmacology. 20:1507-1512
The incubation in vitro of norethynodrel with the postmitochondrial supernatant from rat liver results in the formation of three intermediary metabolites, namely the 3α- and 3β-hydroxy derivatives and norethindrone. These three steroids are further
Autor:
JT Gidley, RI Freudenthal, Dolores R. Brine, L Testino, Monroe E. Wall, Roni Rosenfeld, HD Christensen, C Pitt, G Boegli
Publikováno v:
Science (New York, N.Y.). 172(3979)
The 11-hydroxy metabolites of Delta(8).- and Delta(9)-tetrahydrocannabinol are more active than the parent compounds when administered to mice by either the intravenous or intracerebral route. Both Delta(8)- and Delta(9)-tetrahydrocannabinol are rapi
Publikováno v:
International journal of toxicology [Int J Toxicol] 2001 Sep-Oct; Vol. 20 (5), pp. 269-74.
Autor:
Freudenthal RI, Anderson DP
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 1997 May 21; Vol. 89 (10), pp. 734; author reply 735-6.
Autor:
Freudenthal RI; First Chemical Corporation, Pascagoula, Mississippi 39568, USA., Anderson DP
Publikováno v:
Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 1995 Feb; Vol. 21 (1), pp. 199-202; discussion 203-5.
Autor:
Freudenthal RI, Anderson DP
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 1994 Jan 05; Vol. 86 (1), pp. 59-62.